| University Of California Davis Medical Center | |
| 2315 Stockton Boulevard, Sacramento, California 95817 | |
| (916) 734-2011 | |
| Name | University Of California Davis Medical Center |
|---|---|
| Type | Acute Care Hospital |
| Location | 2315 Stockton Boulevard, Sacramento, California |
| Ownership | Government - Hospital District or Authority |
| Emergency Services | Yes |
| Medicare ID (CCN) | 050599 |
| NPI Number | 1013062033 |
| Organization Name | SUSAN LEWIS, L.C.S.W. |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 530-306-0625 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1104203082 |
| Organization Name | UC DAVIS MEDICAL CENTER |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-734-8730 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1154302727 |
| Organization Name | UNIVERSITY OF CALIFORNIA, DAVIS, MEDICAL CENTER |
| Address | 2315 Stockton Blvd, Pssb 2100, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-734-5016 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1154475754 |
| Organization Name | UC DAVIS MEDICAL CENTER |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 916-734-2488 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1235561879 |
| Organization Name | UNIVERSITY OF CALIFORNIA, DAVIS |
| Address | 4150 V St Ste 1300, Sacramento, CA 95817 |
| Hospital Type | Chronic Disease Hospital |
| Phone Number | 916-734-2583 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1275870412 |
| Organization Name | UC DAVIS HOSPITAL |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 916-734-2011 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1285774109 |
| Organization Name | UC DAVIS UNIV DENTAL ASSOCIATES |
| Doing Business As | UNIVERSITY DENTAL ASSOCIATES |
| Address | 2521 Stockton Blvd, Room 5200, Sacramento, CA 95817 |
| Hospital Type | Special Hospital |
| Phone Number | 916-734-5408 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1306922547 |
| Organization Name | UC DAVIS MEDICAL CENTER |
| Address | 2521 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 916-734-7621 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1316025091 |
| Organization Name | UC DAVIS HEALTH SYSTEM |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-734-5292 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1346554631 |
| Organization Name | REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| Doing Business As | UNIVERSITY OF CALIFORNIA, DAVIS - TRANSPLANT |
| Address | 2315 Stockton Blvd, Room 1018, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-734-2111 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1366493124 |
| Organization Name | UC DAVIS MEDICAL CENTER |
| Address | 2825 50th St, Sacramento, CA 95817 |
| Hospital Type | Chronic Disease Hospital - Children |
| Phone Number | 916-703-0413 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1366719064 |
| Organization Name | UC DAVIS MEDICAL CENTER |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | Rehabilitation Hospital |
| Phone Number | 916-734-6730 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1457615759 |
| Organization Name | UC DAVIS HEALTH SYSTEMS |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 800-823-4543 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1467896191 |
| Organization Name | UC DAVIS MEDICAL CENTER |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-734-7040 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1477649390 |
| Organization Name | REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-734-2011 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1528449949 |
| Organization Name | UC DAVIS MEDICAL CENTER |
| Address | 4860 Y St Ste 3800, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-734-2011 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1548544232 |
| Organization Name | UNIVERSITY OF CALIFORNIA MEDICAL GROUP |
| Address | 2825 50th St, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-703-0371 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1598088791 |
| Organization Name | UCDAVIS MEDICAL CENTER |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 916-734-0412 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1699986273 |
| Organization Name | TERRI GOEHRING |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 916-734-2583 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1710918545 |
| Organization Name | REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| Doing Business As | UNIVERSITY OF CALIFORNIA DAVIS MEDICAL CENTER |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-734-9200 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1760536601 |
| Organization Name | UNIVERSITY OF CAIFORNIA, DAVIS MEDICAL CENTER |
| Doing Business As | UNIVERSITY OF CAIFORNIA, DAVIS MEDICAL CENTER |
| Address | 2315 Stockton Blvd, Pssb 1300, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-734-2583 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1811993900 |
| Organization Name | UNIVERSITY OF CALIFORNIA DAVIS MEDICAL CENTER |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-734-0855 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1861612442 |
| Organization Name | REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| Doing Business As | UC DAVIS MEDICAL CENTER |
| Address | 2825 50th St, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-703-0313 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1912980103 |
| Organization Name | UC DAVIS MEDICAL CENTER |
| Address | 2315 Stockton Blvd, Room 4206, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 916-734-2841 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1922357706 |
| Organization Name | REGENTS OF UNIV OF CALIF-DAVIS |
| Address | 2315 Stockton Blvd, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital - Children |
| Phone Number | 916-703-2371 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| NPI Number | 1932589082 |
| Organization Name | UC DAVIS MEDICAL CENTER |
| Address | 4860 Y St Ste 3800, Sacramento, CA 95817 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 916-734-2807 |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
A nasal vaccine in development by researchers at The University of Texas at Austin has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. Results from a small pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long-lasting, which could have significant global implications in controlling future outbreaks.
Pioneering research led by Johns Hopkins scientists on the use of partially matched bone marrow transplants to wipe out sickle cell disease has been selected as one of the Top 10 Clinical Research Achievements of 2012 by the Clinical Research Forum.
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Imagine for a moment that you work in a hospital emergency room. And just outside the door, a man has collapsed from a heart attack.
Consensus document on the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by The European COST Action B26, The European Society of Hypertension and The European Respiratory Society.
› Verified 7 days ago
Mercy General Hospital Acute Care Hospital Location: 4001 J St, Sacramento, California 95819 Phone: (916) 453-4453 | |
Sutter Medical Center, Sacramento Acute Care Hospital Location: 2825 Capitol Avenue, Sacramento, California 95816 Phone: (916) 733-8999 | |
Kaiser Foundation Hospital - Sacramento Acute Care Hospital Location: 2025 Morse Avenue, Sacramento, California 95825 Phone: (916) 973-5000 | |
Methodist Hospital Of Sacramento Acute Care Hospital Location: 7500 Hospital Drive, Sacramento, California 95823 Phone: (916) 423-6010 | |
University Of California Davis Medical Center Acute Care Hospital Location: 2315 Stockton Boulevard, Sacramento, California 95817 Phone: (916) 734-2011 | |
Kaiser Foundation Hosp So Sacramento Acute Care Hospital Location: 6600 Bruceville Road, Sacramento, California 95823 Phone: (916) 688-2000 |